![Matthew Malaghan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Malaghan
Director/Board Member at Malcorp Biodiscoveries Ltd.
Profile
Matthew Malaghan is currently a Director at Malcorp Biodiscoveries Ltd.
He previously worked as a Trustee at The Malaghan Institute of Medical Research.
Matthew Malaghan active positions
Companies | Position | Start |
---|---|---|
Malcorp Biodiscoveries Ltd.
![]() Malcorp Biodiscoveries Ltd. Pharmaceuticals: GenericHealth Technology Malcorp Biodiscoveries Ltd. develops drugs for the treatment of cancer. The company is headquartered in Wellington, New Zealand. | Director/Board Member | - |
Former positions of Matthew Malaghan
Companies | Position | End |
---|---|---|
The Malaghan Institute of Medical Research
![]() The Malaghan Institute of Medical Research BiotechnologyHealth Technology The Malaghan Institute of Medical Research is a world-leading independent biomedical research institute located in Kelburn Parade, New Zealand. The institute focuses on key areas of research such as cancer, asthma and allergy, gut health, brain health, and infectious disease. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Malcorp Biodiscoveries Ltd.
![]() Malcorp Biodiscoveries Ltd. Pharmaceuticals: GenericHealth Technology Malcorp Biodiscoveries Ltd. develops drugs for the treatment of cancer. The company is headquartered in Wellington, New Zealand. | Health Technology |
The Malaghan Institute of Medical Research
![]() The Malaghan Institute of Medical Research BiotechnologyHealth Technology The Malaghan Institute of Medical Research is a world-leading independent biomedical research institute located in Kelburn Parade, New Zealand. The institute focuses on key areas of research such as cancer, asthma and allergy, gut health, brain health, and infectious disease. | Health Technology |
- Stock Market
- Insiders
- Matthew Malaghan